دورية أكاديمية
أعرض في EDS

Effect of pecan nuts and extra-virgin olive oil on glycemic profile and nontraditional anthropometric indexes in patients with coronary artery disease: a randomized clinical trial.

التفاصيل البيبلوغرافية
العنوان: Effect of pecan nuts and extra-virgin olive oil on glycemic profile and nontraditional anthropometric indexes in patients with coronary artery disease: a randomized clinical trial.
المؤلفون: Dos Santos JL; Graduate Program in Health Sciences (Cardiology), Instituto de Cardiologia/Fundação Universitária de Cardiologia do Rio Grande do Sul (IC/FUC), Porto Alegre, Brazil., Portal VL; Graduate Program in Health Sciences (Cardiology), Instituto de Cardiologia/Fundação Universitária de Cardiologia do Rio Grande do Sul (IC/FUC), Porto Alegre, Brazil., Markoski MM; Graduate Program in Biosciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil., de Quadros AS; Graduate Program in Health Sciences (Cardiology), Instituto de Cardiologia/Fundação Universitária de Cardiologia do Rio Grande do Sul (IC/FUC), Porto Alegre, Brazil., Bersch-Ferreira Â; HCor Research Institute, Hospital do Coração (IP-HCor), São Paulo, Brazil., Marcadenti A; Graduate Program in Health Sciences (Cardiology), Instituto de Cardiologia/Fundação Universitária de Cardiologia do Rio Grande do Sul (IC/FUC), Porto Alegre, Brazil. marcadenti.aline@gmail.com.; HCor Research Institute, Hospital do Coração (IP-HCor), São Paulo, Brazil. marcadenti.aline@gmail.com.
المصدر: European journal of clinical nutrition [Eur J Clin Nutr] 2022 Jun; Vol. 76 (6), pp. 827-834. Date of Electronic Publication: 2021 Nov 22.
نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8804070 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5640 (Electronic) Linking ISSN: 09543007 NLM ISO Abbreviation: Eur J Clin Nutr Subsets: MEDLINE
أسماء مطبوعة: Publication: <2003->: London : Nature Publishing Group
Original Publication: London : J. Libbey, c1988-
مواضيع طبية MeSH: Cardiovascular Diseases*/prevention & control , Carya* , Coronary Artery Disease* , Diet, Mediterranean*, Blood Glucose ; Humans ; Nuts ; Olive Oil
مستخلص: Background/objectives: The influence of cardioprotective foods on nontraditional indexes related to dysglycemia and body fat distribution is unknown in individuals with coronary artery disease (CAD). This study aimed to evaluate the effect of a healthy diet supplemented with pecan nuts or extra-virgin olive oil on glycemic profile and adipose tissue dysfunction assessed by anthropometric indexes in patients with stable CAD.
Subjects/methods: In a randomized, pragmatic, parallel clinical trial lasting 12 weeks, 204 individuals were allocated to three interventions: a healthy diet (control group [CG], n = 67), a healthy diet plus 30 g/day of pecan nuts (pecan nut group [PNG], n = 68), or a healthy diet plus 30 mL/day of extra-virgin olive oil (olive oil group [OOG], n = 69). Triglyceride-glucose (TyG) index (primary outcome) and other markers of glycemic profile were evaluated, and nontraditional anthropometric indexes as well. Diet quality was assessed according to the Alternate Healthy Eating Index (mAHEI).
Results: After adjustment for baseline values, use of antidiabetic drugs and insulin, there were no differences in both glycemic and anthropometric profiles according to groups at the end of the study. PNG improved the quality of the diet in comparison to other groups (final mAHEI scores: CG: 19 ± 7.5; PNG: 26 ± 8; OOG: 18.9 ± 6; P < 0.001).
Conclusions: There was no difference regarding glycemic and anthropometric parameters according to interventions in patients with stable CAD. However, adding pecan nuts to a healthy diet may improve its quality. Further studies must be conducted considering dietary interventions on secondary cardiovascular prevention setting.
Clinical Trials Identifier Number: NCT02202265. First Posted: July 2014; Last Update: September 2020.
(© 2021. The Author(s), under exclusive licence to Springer Nature Limited.)
References: Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation 2021;143:e254–e743. (PMID: 3350184810.1161/CIR.0000000000000950)
Su G, Mi S, Tao H, Li Z, Yang H, Zheng H, et al. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol. 2011;10:19. (PMID: 21349201305676510.1186/1475-2840-10-19)
Xia J, Yin C. Glucose variability and coronary artery disease. Heart Lung Circ. 2019;28:553–9. (PMID: 3052784910.1016/j.hlc.2018.10.019)
Khan SH, Sobia F, Niazi NK, Manzoor SM, Fazal N, Ahmad F. Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetol Metab Syndr. 2018;10:74. (PMID: 30323862617383210.1186/s13098-018-0376-8)
Silva A, Caldas APS, Rocha DMUP, Bressan J. Triglyceride-glucose index predicts independently type 2 diabetes mellitus risk: a systematic review and meta-analysis of cohort studies. Prim Care Diabetes. 2020;14:584–93. (PMID: 3292869210.1016/j.pcd.2020.09.001)
Hu C, Zhang J, Liu J, Liu Y, Gao A, Zhu Y, et al. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China. Cardiovasc Diabetol. 2020;19:116. (PMID: 32703284737976810.1186/s12933-020-01091-8)
da Silva A, Caldas APS, Hermsdorff HHM, Bersch-Ferreira ÂC, Torreglosa CR, Weber B, et al. Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care. Cardiovasc Diabetol. 2019;18:89. (PMID: 31296225662505010.1186/s12933-019-0893-2)
Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444:875–80. (PMID: 1716747610.1038/nature05487)
Luo Y, Ma X, Shen Y, Xu Y, Xiong Q, Zhang X, et al. Neck circumference as an effective measure for identifying cardio-metabolic syndrome: a comparison with waist circumference. Endocrine. 2017;55:822–30. (PMID: 2779681310.1007/s12020-016-1151-y)
Garofallo SB, Portal VL, Markoski MM, Dias LD, de Quadros AS, Marcadenti A. Correlations between traditional and nontraditional indicators of adiposity, inflammation, and monocyte subtypes in patients with stable coronary artery disease. J Obes. 2019;2019:3139278. (PMID: 31354986663768710.1155/2019/3139278)
Han L, Fu KL, Zhao J, Wang ZH, Tang MX, Wang J, et al. Visceral adiposity index score indicated the severity of coronary heart disease in Chinese adults. Diabetol Metab Syndr. 2014;6:143. (PMID: 25587360429299510.1186/1758-5996-6-143)
Chiavaroli L, Viguiliouk E, Nishi SK, Blanco Mejia S, Rahelić D, Kahleová H, et al. DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses. Nutrients. 2019;11:338. (PMID: 641323510.3390/nu11020338)
Rees K, Takeda A, Martin N, Ellis L, Wijesekara D, Vepa A, et al. Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2019;3:CD009825. (PMID: 30864165)
Widmer RJ, Flammer AJ, Lerman LO, Lerman A. The Mediterranean diet, its components, and cardiovascular disease. Am J Med. 2015;128:229–38. (PMID: 2544761510.1016/j.amjmed.2014.10.014)
Tindall AM, Johnston EA, Kris-Etherton PM, Petersen KS. The effect of nuts on markers of glycemic control: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2019;109:297–314. (PMID: 30722007730743710.1093/ajcn/nqy236)
Santangelo C, Filesi C, Varì R, Scazzocchio B, Filardi T, Fogliano V, et al. Consumption of extra-virgin olive oil rich in phenolic compounds improves metabolic control in patients with type 2 diabetes mellitus: a possible involvement of reduced levels of circulating visfatin. J Endocrinol Investig. 2016;39:1295–301. (PMID: 10.1007/s40618-016-0506-9)
Estruch R, Martínez-González MA, Corella D, Salas-Salvadó J, Fitó M, Chiva-Blanch G, et al. Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial. Lancet Diabetes Endocrinol. 2019;7:e6–e17. (PMID: 3100362610.1016/S2213-8587(19)30074-9)
Campos VP, Portal VL, Markoski MM, Quadros AS, Bersch-Ferreira ÂC, Garavaglia J, et al. Effects of a healthy diet enriched or not with pecan nuts or extra-virgin olive oil on the lipid profile of patients with stable coronary artery disease: a randomised clinical trial. J Hum Nutr Diet. 2020;33:439–50. (PMID: 3185637910.1111/jhn.12727)
Thomazella MC, Góes MF, Andrade CR, Debbas V, Barbeiro DF, Correia RL, et al. Effects of high adherence to mediterranean or low-fat diets in medicated secondary prevention patients. Am J Cardiol. 2011;108:1523–9. (PMID: 2189008110.1016/j.amjcard.2011.07.008)
Yubero-Serrano EM, Fernandez-Gandara C, Garcia-Rios A, Rangel-Zuñiga OA, Gutierrez-Mariscal FM, Torres-Peña JD, et al. Mediterranean diet and endothelial function in patients with coronary heart disease: an analysis of the CORDIOPREV randomized controlled trial. PLoS Med. 2020;17:e1003282. (PMID: 32903262748087210.1371/journal.pmed.1003282)
Martínez-González MA, Fernandez-Lazaro CI, Toledo E, Díaz-López A, Corella D, Goday A, et al. Carbohydrate quality changes and concurrent changes in cardiovascular risk factors: a longitudinal analysis in the PREDIMED-Plus randomized trial. Am J Clin Nutr. 2020;111:291–306. (PMID: 3186821010.1093/ajcn/nqz298)
Babiker R, Elmusharaf K, Keogh MB, Saeed AM. Effect of Gum Arabic (Acacia Senegal) supplementation on visceral adiposity index (VAI) and blood pressure in patients with type 2 diabetes mellitus as indicators of cardiovascular disease (CVD): a randomized and placebo-controlled clinical trial. Lipids Health Dis. 2018;17:56. (PMID: 29558953585943410.1186/s12944-018-0711-y)
Portal VL, Markoski MM, Quadros AS, Garofallo S, Santos JL, Oliveira A, et al. Effect of polymorphisms in the CD36 and STAT3 genes on different dietary interventions among patients with coronary artery disease: study protocol for a randomized controlled trial. Trials 2016;17:437. (PMID: 27596284501184410.1186/s13063-016-1564-1)
Weschenfelder C, Gottschall CBA, Markoski MM, Portal VL, de Quadros AS, Bersch-Ferreira ÂC et al. Effects of supplementing a healthy diet with pecan nuts or extra-virgin olive oil on inflammatory profile of patients with stable coronary artery disease: a randomized clinical trial. Br J Nutr. 2021;11:1–27. https://doi.org/10.1017/S0007114521001513 .
Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33:920–2. (PMID: 20067971284505210.2337/dc09-1825)
Ioachimescu AG, Brennan DM, Hoar BM, Hoogwerf BJ. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study. Obesity. 2010;18:1836–44. (PMID: 2003528410.1038/oby.2009.453)
Brundavani V, Murthy SR, Kurpad AV. Estimation of deep-abdominal-adipose-tissue (DAAT) accumulation from simple anthropometric measurements in Indian men and women. Eur J Clin Nutr. 2006;60:658–66. (PMID: 1639157210.1038/sj.ejcn.1602366)
Dehghan M, Mente A, Teo KK, Gao P, Sleight P, Dagenais G, et al. Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countries. Circulation. 2012;126:2705–12. (PMID: 2321299610.1161/CIRCULATIONAHA.112.103234)
Weber B, Bersch-Ferreira ÂC, Torreglosa CR, Marcadenti A, Lara ES, da Silva JT, et al. Implementation of a Brazilian Cardioprotective Nutritional (BALANCE) Program for improvement on quality of diet and secondary prevention of cardiovascular events: a randomized, multicenter trial. Am Heart J. 2019;215:187–97. (PMID: 3134911010.1016/j.ahj.2019.06.010)
Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65:1220S–1228S. (PMID: 909492610.1093/ajcn/65.4.1220S)
Reis Ribeiro S, Klein B, Machado Ribeiro Q, Duarte Dos Santos I, Gomes Genro AL, de Freitas, et al. Chemical composition and oxidative stability of eleven pecan cultivars produced in southern Brazil. Food Res Int. 2020;136:109596. (PMID: 3284662110.1016/j.foodres.2020.109596)
Belury MA, Cole RM, Snoke DB, Banh T, Angelotti A. Linoleic acid, glycemic control and Type 2 diabetes. Prostaglandins Leukot Ess Fat Acids. 2018;132:30–33. (PMID: 10.1016/j.plefa.2018.03.001)
Qian F, Korat AA, Malik V, Hu FB. Metabolic Effects of Monounsaturated Fatty Acid-Enriched Diets Compared With Carbohydrate or Polyunsaturated Fatty Acid-Enriched Diets in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care. 2016;39:1448–57. (PMID: 27457635495592610.2337/dc16-0513)
Silva FM, Kramer CK, de Almeida JC, Steemburgo T, Gross JL, Azevedo MJ. Fiber intake and glycemic control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials. Nutr Rev. 2013;71:790–801. (PMID: 2418056410.1111/nure.12076)
Rocca AS, LaGreca J, Kalitsky J, Brubaker PL. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1. Endocrinology. 2001;142:1148–55. (PMID: 1118153010.1210/endo.142.3.8034)
Bozzetto L, Prinster A, Annuzzi G, Costagliola L, Mangione A, Vitelli A, et al. Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients. Diabetes Care. 2012;35:1429–35. (PMID: 22723581337957810.2337/dc12-0033)
Iwasaki T, Tomeno W, Yoneda M, Inamori M, Shirakawa J, Imajo K, et al. Non-alcoholic fatty liver disease adversely affects the glycemic control afforded by sitagliptin. Hepatogastroenterology. 2012;59:1522–5. (PMID: 22155853)
Viguiliouk E, Kendall CW, Blanco Mejia S, Cozma AI, Ha V, Mirrahimi A, et al. Effect of tree nuts on glycemic control in diabetes: a systematic review and meta-analysis of randomized controlled dietary trials. PLoS One. 2014;9:e103376. (PMID: 25076495411617010.1371/journal.pone.0103376)
Ribeiro PVM, Silva A, Almeida AP, Hermsdorff HH, Alfenas RC. Effect of chronic consumption of pistachios (Pistacia vera L.) on glucose metabolism in pre-diabetics and type 2 diabetics: a systematic review. Crit Rev Food Sci Nutr. 2019;59:1115–23. (PMID: 2904002510.1080/10408398.2017.1392290)
Del Gobbo LC, Falk MC, Feldman R, Lewis K, Mozaffarian D. Effects of tree nuts on blood lipids, apolipoproteins, and blood pressure: systematic review, meta-analysis, and dose-response of 61 controlled intervention trials. Am J Clin Nutr. 2015;102:1347–56. (PMID: 26561616465845810.3945/ajcn.115.110965)
McKay DL, Eliasziw M, Chen CYO, Blumberg JB. A Pecan-Rich Diet Improves Cardiometabolic Risk Factors in Overweight and Obese Adults: A Randomized Controlled Trial. Nutrients. 2018;10:339. (PMID: 587275710.3390/nu10030339)
Venkatachalam M, Kshirsagar HH, Seeram NP, Heber D, Thompson TE, Roux KH, et al. Biochemical composition and immunological comparison of select pecan [Carya illinoinensis (Wangenh.) K. Koch] cultivars. J Agric Food Chem. 2007;55:9899–907. (PMID: 1797344410.1021/jf0714721)
Mazidi M, Vatanparast H, Katsiki N, Banach M. The impact of nuts consumption on glucose/insulin homeostasis and inflammation markers mediated by adiposity factors among American adults. Oncotarget. 1827;9:31173–86. (PMID: 10.18632/oncotarget.25168)
Ferramosca A, Conte A, Burri L, Berge K, De Nuccio F, Giudetti AM, et al. A krill oil supplemented diet suppresses hepatic steatosis in high-fat fed rats. PLoS One. 2012;7:e38797. (PMID: 22685607336986210.1371/journal.pone.0038797)
Röder PV, Geillinger KE, Zietek TS, Thorens B, Koepsell H, Daniel H. The role of SGLT1 and GLUT2 in intestinal glucose transport and sensing. PLoS One. 2014;9:e89977. (PMID: 24587162393595510.1371/journal.pone.0089977)
Zhang ZF, Li Q, Liang J, Dai XQ, Ding Y, Wang JB, et al. Epigallocatechin-3-O-gallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition. Phytomedicine. 2010;17:14–8. (PMID: 1981968210.1016/j.phymed.2009.09.007)
Schwingshackl L, Lampousi AM, Portillo MP, Romaguera D, Hoffmann G, Boeing H. Olive oil in the prevention and management of type 2 diabetes mellitus: a systematic review and meta-analysis of cohort studies and intervention trials. Nutr Diabetes. 2017;7:e262. (PMID: 28394365543609210.1038/nutd.2017.12)
Pedan V, Popp M, Rohn S, Nyfeler M, Bongartz A. Characterization of Phenolic Compounds and Their Contribution to Sensory Properties of Olive Oil. Molecules. 2019;24:2041. (PMID: 660043510.3390/molecules24112041)
Tekaya M, Mechri B, Bchir A, Attia F, Cheheb H, Daassa M, et al. Effect of nutrient-based fertilisers of olive trees on olive oil quality. J Sci Food Agric. 2013;93:2045–52. (PMID: 2340110910.1002/jsfa.6015)
European Comission. Brussels: Official Journal of the European Union: 2012. Accessed 27 Mar 2021. https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2012:136:FULL:EN:PDF .
Meza CA, La Favor JD, Kim DH, Hickner RC. Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS? Int J Mol Sci. 2019;20:3775. (PMID: 669631310.3390/ijms20153775)
Mach F, Ray KK, Wiklund O, Corsini A, Catapano AL, Bruckert E, et al. Adverse effects of statin therapy: perception vs. the evidence—focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Eur Heart J. 2018;39:2526–39. (PMID: 29718253604741110.1093/eurheartj/ehy182)
Gelli C, Tarocchi M, Abenavoli L, Di Renzo L, Galli A, De Lorenzo A. Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease. World J Gastroenterol. 2017;23:3150–62. (PMID: 28533672542305210.3748/wjg.v23.i17.3150)
سلسلة جزيئية: ClinicalTrials.gov NCT02202265
المشرفين على المادة: 0 (Blood Glucose)
0 (Olive Oil)
تواريخ الأحداث: Date Created: 20211123 Date Completed: 20220614 Latest Revision: 20221026
رمز التحديث: 20221213
DOI: 10.1038/s41430-021-01045-7
PMID: 34811509
قاعدة البيانات: MEDLINE
الوصف
تدمد:1476-5640
DOI:10.1038/s41430-021-01045-7